The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study

Hélène Haguet, Céline Bouvy, Anne Sophie Delvigne, Elise Modaffari, Adeline Wannez, Pierre Sonveaux, Jean Michel Dogné, Jonathan Douxfils

Research output: Contribution to journalArticlepeer-review

38 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science